Semnur Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 12.8% | 12.8% | -0.5% |
| FY2023 | -1.7% | -1.7% | 1.2% |
| FY2024 | 11.0% | 11.0% | -70.2% |
| FY2025 | 773.1% | 773.1% | -11,918.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 12.8% | 12.8% | -0.5% |
| FY2023 | -1.7% | -1.7% | 1.2% |
| FY2024 | 11.0% | 11.0% | -70.2% |
| FY2025 | 773.1% | 773.1% | -11,918.0% |